Keytruda Interactions
There are 595 drugs known to interact with Keytruda (pembrolizumab), along with 9 disease interactions. Of the total drug interactions, 3 are major, and 592 are moderate.
- View all 595 medications that may interact with Keytruda
- View Keytruda disease interactions (9)
Most frequently checked interactions
View interaction reports for Keytruda (pembrolizumab) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- carboplatin
- CoQ10 (ubiquinone)
- dexamethasone
- Eliquis (apixaban)
- famotidine
- folic acid
- gabapentin
- levothyroxine
- lisinopril
- lorazepam
- losartan
- melatonin
- metformin
- metoprolol
- MiraLAX (polyethylene glycol 3350)
- omeprazole
- ondansetron
- oxycodone
- pantoprazole
- prednisone
- prochlorperazine
- tramadol
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Keytruda disease interactions
There are 9 disease interactions with Keytruda (pembrolizumab) which include:
- immune system disorder
- HSCT
- myasthenia gravis
- organ transplant
- colitis
- hepatic impairment
- multiple myeloma
- pneumonitis
- thyroid disease
Report options
More about Keytruda (pembrolizumab)
- Keytruda consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (258)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
